Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Sanzenbacher

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 4, 2015
[Strategic considerations on the design and choice of animal models for non-clinical investigations of cell-based medicinal products]Jörg Lehmann, Ronny M Schulz, Ralf Sanzenbacher
Human Gene Therapy|January 18, 2012
The European hospital exemption clause-new option for gene therapy?Christian J Buchholz, Ralf Sanzenbacher, Silke Schüle
Advances in Experimental Medicine and Biology|September 17, 2015
Regulation of Clinical Trials with Advanced Therapy Medicinal Products in GermanyMatthias Renner, Brigitte Anliker, Ralf Sanzenbacher, et al.
Trends in Molecular Medicine|December 1, 2018
Linking Scattered Stem Cell-Based Data to Advance Therapeutic DevelopmentAndreas Kurtz, Magdi Elsallab, Ralf Sanzenbacher, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 16, 2015
[Xenogeneic cell therapeutics: Treatment of type 1 diabetes using porcine pancreatic islets and islet cells]Antonia W Godehardt, Dagmar Schilling-Leiß, Ralf Sanzenbacher, et al.
Molecular Immunology|August 30, 2005
IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activityHeide Muckenfuss, Matthias Hamdorf, Andris Avots, et al.
Molecular Biotechnology|May 13, 2006
An inducible T7 RNA polymerase-dependent plasmid systemMatthias Hamdorf, Heide Muckenfuss, Ulrich Tschulena, et al.
ALTEX|August 31, 2007
Safety testing of cell-based medicinal products: opportunities for the monocyte activation test for pyrogensThomas Montag, Ingo Spreitzer, Bettina Löschner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2005
Stable transduction of primary human monocytes by simian lentiviral vector PBjMichael D Mühlebach, Nina Wolfrum, Silke Schüle, et al.
The Journal of General Virology|August 17, 2012
Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/threonine phosphorylation statusFerdinand Kopietz, Ananda Ayyappan Jaguva Vasudevan, Melanie Krämer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 4, 2015
[Strategic considerations on the design and choice of animal models for non-clinical investigations of cell-based medicinal products]Jörg Lehmann, Ronny M Schulz, Ralf Sanzenbacher
Human Gene Therapy|January 18, 2012
The European hospital exemption clause-new option for gene therapy?Christian J Buchholz, Ralf Sanzenbacher, Silke Schüle
Advances in Experimental Medicine and Biology|September 17, 2015
Regulation of Clinical Trials with Advanced Therapy Medicinal Products in GermanyMatthias Renner, Brigitte Anliker, Ralf Sanzenbacher, et al.
Trends in Molecular Medicine|December 1, 2018
Linking Scattered Stem Cell-Based Data to Advance Therapeutic DevelopmentAndreas Kurtz, Magdi Elsallab, Ralf Sanzenbacher, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 16, 2015
[Xenogeneic cell therapeutics: Treatment of type 1 diabetes using porcine pancreatic islets and islet cells]Antonia W Godehardt, Dagmar Schilling-Leiß, Ralf Sanzenbacher, et al.
Molecular Immunology|August 30, 2005
IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activityHeide Muckenfuss, Matthias Hamdorf, Andris Avots, et al.
Molecular Biotechnology|May 13, 2006
An inducible T7 RNA polymerase-dependent plasmid systemMatthias Hamdorf, Heide Muckenfuss, Ulrich Tschulena, et al.
ALTEX|August 31, 2007
Safety testing of cell-based medicinal products: opportunities for the monocyte activation test for pyrogensThomas Montag, Ingo Spreitzer, Bettina Löschner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2005
Stable transduction of primary human monocytes by simian lentiviral vector PBjMichael D Mühlebach, Nina Wolfrum, Silke Schüle, et al.
The Journal of General Virology|August 17, 2012
Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/threonine phosphorylation statusFerdinand Kopietz, Ananda Ayyappan Jaguva Vasudevan, Melanie Krämer, et al.
Pageof 2